Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
home:othertreatments:rapamycin [01.03.2012] – external edit 127.0.0.1home:othertreatments:rapamycin [09.14.2022] (current) – external edit 127.0.0.1
Line 4: Line 4:
 <relatedarticle> [[home:patients:assessing_literature:palliative|Palliative vs. curative treatments]] </article> <relatedarticle> [[home:patients:assessing_literature:palliative|Palliative vs. curative treatments]] </article>
  
-Sirolimus, also known as rapamycin, is an immunosuppressant drug used to prevent rejection in organ transplantation and has recently been prescribed for patients with certain chronic inflammatory diseases such as Alzheimers disease.(({{pubmed>long:20862226}}))+Sirolimus, also known as rapamycin, is an immunosuppressant drug used to prevent rejection in organ transplantation and has recently been prescribed for patients with certain chronic inflammatory diseases such as Alzheimers disease.(({{pmid>long:20862226}}))
  
  
Line 12: Line 12:
  
  
-//**Trevor Marshall, PhD** [[http://www.marshallprotocol.com/view_topic.php?id=13795&forum_id=39&jump_to=207432#p207432|MarshallProtocol.com]]//</blockquote>+//**Trevor Marshall, PhD** [[https://www.marshallprotocol.com/view_topic.php?id=13795&forum_id=39&jump_to=207432#p207432|MarshallProtocol.com]]//</blockquote>
  
 {{tag>non-MP_therapies}} {{tag>non-MP_therapies}}
  
  
-===== References =====+ 
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
 +
 +===== References =====
 +</nodisp>
  
home/othertreatments/rapamycin.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.